predicting-vivo-payloads-delivery-using-blood-brain-tumor-barrier

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish

Highly selective by nature, the blood-brain barrier (BBB) is essential for the brain homeostasis in physiological conditions. However, in the context of ...

University of Helsinki

The recent discovery of meningeal lymphatic vessels (LVs) has raised interest in their possible involvement in neuropathological processes, yet little is known about their development or maintenance. We show here that meningeal LVs develop postnatally, appearing first around the foramina in the basal parts of the skull and spinal canal, sprouting along the blood vessels and cranial and spinal nerves to various parts of the meninges surrounding the central nervous system (CNS). VEGF-C, expressed mainly in vascular smooth muscle cells, and VEGFR3 in lymphatic endothelial cells were essential for their development, whereas VEGF-D deletion had no effect. Surprisingly, in adult mice, the LVs showed regression after VEGF-C or VEGFR3 deletion, administration of the tyrosine kinase inhibitor sunitinib, or expression of VEGF-C/D trap, which also compromised the lymphatic drainage function. Conversely, an excess of VEGF-C induced meningeal lymphangiogenesis. The plasticity and regenerative potential of meningeal LVs should allow manipulation of cerebrospinal fluid drainage and neuropathological processes in the CNS.

Development and plasticity of meningeal lymphatic vessels.

Vascular endothelial growth factors (VEGFs) are best known for their involvement in orchestrating the development and maintenance of the blood and lymphatic vascular systems. VEGFs are secreted by a variety of cells and they bind to their cognate tyrosine kinase VEGF receptors (VEGFRs) in endothelial cells to elicit various downstream effects. In recent years, there has been tremendous progress in elucidating different VEGF/VEGFR signaling functions in both the blood and lymphatic vascular systems. Here, and in the accompanying poster, we present key elements of the VEGF/VEGFR pathway and highlight the classical and newly discovered functions of VEGF signaling in blood and lymphatic vessel development and pathology.

Vascular endothelial growth factor signaling in development and disease.

The lymphatic vessels can be selectively stimulated to grow in adult mice, rats and pigs by application of viral vectors expressing the lymphangiogenic factors VEGF-C or VEGF-D. Vice versa, lymphangiogenesis in various pathological settings can be inhibited by the blocking of the VEGF-C/VEGFR3 interaction using a ligand-binding soluble form of VEGFR3. Furthermore, the recently discovered plasticity of meningeal and lacteal lymphatic vessels provides novel opportunities for their manipulation in disease. Adenoviral and adeno-associated viral vectors (AAVs) provide suitable tools for establishing short- and long-term gene expression, respectively and adenoviral vectors have already been used in clinical trials. As an example, we describe here ways to manipulate the meningeal lymphatic vasculature in the adult mice via AAV-mediated gene delivery. The possibility of stimulation and inhibition of lymphangiogenesis in adult mice has enabled the analysis of the role and function of lymphatic vessels in mouse models of disease.

Sinem Karaman

Research Programs Unit,
Translational Cancer Medicine Research Program,
Wihuri Research Institute,
Biomedicum Helsinki,
Research Programs Unit, Translational Cancer Medicine Research Program,
Wihuri Research Institute, Biomedicum Helsinki

University of Helsinki

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish

Sinem Karaman

Research Programs Unit,Translational Cancer Medicine Research Program,Wihuri Research Institute,Biomedicum Helsinki,Research Programs Unit, Translational Cancer Medicine Research Program,Wihuri Research Institute, Biomedicum Helsinki

University of Helsinki

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish

Research Programs Unit,
Translational Cancer Medicine Research Program,
Wihuri Research Institute,
Biomedicum Helsinki,
Research Programs Unit, Translational Cancer Medicine Research Program,
Wihuri Research Institute, Biomedicum Helsinki